The present invention discloses a use of receptor antagonists for manufacturing drugs of preventing, treating, inhibiting, delaying diseases of hyper-activation of NMDA receptor or AMPA receptor, in which the NMDA receptor antagonist is selected from a group consisting of paeonol, baicalein, rutin and ginkgolide A, and the AMPA receptor antagonist is baicalein.本發明係關於一種NMDA受體或AMPA受體拮抗劑的用途,用於製備預防、治療、抑制或延緩因NMDA受體或AMPA受體過度活化之疾病的藥物,其中NMDA受體拮抗劑係選自於由牡丹酚(Paeonol)、黃芩素(Baicalein)、芸香苷(Rutin)、銀杏內酯(Ginkgolide A)及其組合所組成之群組,且AMPA受體拮抗劑係為黃芩素(Baicalein)。